GOLIMUMAB INHIBITS PROGRESSION OF RADIOGRAPHIC DAMAGE IN PATIENTS WITH PSORIATIC ARTHRITIS: 52 WEEK RESULTS FROM THE GO-REVEAL STUDY

被引：0
|
作者：
Kavanaugh, A. [1 ]
van der Heijde, D. [2 ]
Chattopadhyay, Chandra
Gladman, D. [3 ]
Mease, P. [4 ]
McInnes, I. [5 ]
Krueger, G. G. [6 ]
Xu, W. [7 ]
Rahman, M. U. [8 ,9 ]
Zrubek, J. [8 ]
Baratelle, A. [8 ]
Beutler, A.
机构：
[1] Univ Calif San Diego, La Jolla, CA 92093 USA
[2] Leiden Univ, Med Ctr, Leiden, Netherlands
[3] Toronto Western Hosp, Toronto, ON M5T 2S8, Canada
[4] Univ Washington, Swedish Med Ctr, Seattle, WA 98195 USA
[5] Univ Glasgow, Glasgow, Lanark, Scotland
[6] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA
[7] Centocor Res & Dev Inc, Biostat, Malvern, PA USA
[8] Centocor Res & Dev Inc, Immunol, Malvern, PA USA
[9] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
来源：
RHEUMATOLOGY | 2011年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：143 / 143
页数：1
相关论文
共 50 条
  • [31] Secukinumab Provides Improvement in Nail Psoriasis and Inhibition of Radiographic Progression in Psoriatic Arthritis Patients with Nail Phenotype: 52-Week Results from a Phase III Study
    Nash, Peter
    Mease, Philip
    Kirkham, Bruce
    Balsa, Alejandro
    Singhal, Atul
    Quebe-Fehling, Erhard
    Pricop, Luminita
    Gaillez, Corine
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [32] Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment - Results from the induction and maintenance psoriatic arthritis clinical trial 2
    van der Heijde, D.
    Kavanaugh, A.
    Gladman, D. D.
    Antoni, C.
    Krueger, G. G.
    Guzzo, C.
    Zhou, B.
    Dooley, L. T.
    de Vlam, K.
    Geusens, P.
    Birbara, C.
    Halter, D.
    Beutler, A.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (08): : 2698 - 2707
  • [33] Secukinumab provides sustained low rates of radiographic progression in psoriatic arthritis: 52-week results from a phase 3 study, FUTURE 5
    van der Heijde, Desiree
    Mease, Philip J.
    Landewe, Robert B. M.
    Rahman, Proton
    Tahir, Hasan
    Singhal, Atul
    Boettcher, Elke
    Navarra, Sandra
    Zhu, Xuan
    Ligozio, Gregory
    Readie, Aimee
    Mpofu, Shephard
    Pricop, Luminita
    RHEUMATOLOGY, 2020, 59 (06) : 1325 - 1333
  • [34] Evaluation of Improvement in Skin and Nail Psoriasis in Bio-naive Patients With Active Psoriatic Arthritis Treated With Golimumab: Results Through Week 52 of the GO-VIBRANT Study
    Mease, Philip
    Elaine Husni, M.
    Chakravarty, Soumya D.
    Kafka, Shelly
    Parenti, Dennis
    Kim, Lilianne
    Hung Lo, Kim
    Hsia, Elizabeth C.
    Kavanaugh, Arthur
    ACR OPEN RHEUMATOLOGY, 2020, 2 (11) : 640 - 647
  • [35] Golimumab administered every four weeks as a subcutaneous injection in psoriatic arthritis:: Nail, enthesitis, and dactylitis response in the randomized, placebo-controlled, GO-REVEAL study
    Gladman, D.
    Kavanaugh, A.
    McInnes, I.
    Mease, P.
    Gomez-Reino, J. J.
    Papp, K.
    Livingston, J.
    Mudivarthy, S.
    Mack, M.
    Beutler, A.
    Krueger, G. G.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S575 - S575
  • [36] Etanercept (ENBREL®) inhibits radiographic progression in patients with psoriatic arthritis.
    Ory, P
    Sharp, JT
    Salonen, D
    Rubenstein, J
    Mease, PJ
    Kivitiz, A
    Burge, DJ
    Tsuji, W
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S196 - S196
  • [37] GOLIMUMAB ADMINISTERED EVERY FOUR WEEKS AS A SUBCUTANEOUS INJECTION IN PSORIATIC ARTHRITIS: NAIL, ENTHESITIS, AND DACTYLITIS RESPONSE IN THE RANDOMIZED, PLACEBO-CONTROLLED, GO-REVEAL STUDY
    McInnes, Iain
    Gladman, Dafna
    Kavanaugh, Arthur
    Mease, Philip
    Gomez-Reino, Juan
    Papp, Kim
    Zrubek, Julie
    Mudivarthy, Surekha
    Beutler, Anna
    Krueger, Gerald
    RHEUMATOLOGY, 2009, 48 : I58 - I58
  • [38] Safety and Efficacy of Intravenous Golimumab in Patients With Active Psoriatic Arthritis Results Through Week Twenty-Four of the GO-VIBRANT Study
    Kavanaugh, Arthur
    Husni, M. Elaine
    Harrison, Diane D.
    Kim, Lilianne
    Lo, Kim Hung
    Leu, Jocelyn H.
    Hsia, Elizabeth C.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 (11) : 2151 - 2161
  • [39] RADIOGRAPHIC PROGRESSION OF STRUCTURAL JOINT DAMAGE IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS TREATED WITH IXEKIZUMAB OVER 52 WEEKS
    van der Heijde, D.
    Okada, M.
    Lee, C.
    Shuler, C. L.
    Rathmann, S.
    Lin, C. -Y.
    Mease, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 144 - 145
  • [40] Radiographic Progression of Structural Joint Damage in Patients with Active Psoriatic Arthritis Treated with Ixekizumab over 52 Weeks
    van der Heijde, Desiree
    Okada, Masato
    Lee, Chin H.
    Shuler, Catherine
    Rathmann, Suchitrita
    Lin, Chen-Yen
    Mease, Philip J.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
12345